Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RLMD stock: Relmada Therapeutics Inc

Current Rating
Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$0.80
Market Cap
9.7M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
6.16
P/S
-
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-5.3K
FCF
-0.4
Op. Margin
-
Net Margin
-
ROE
-216.40%
ROI
-
ROA
-119.40%
EPS Growth
40.90%
Current Ratio
1.8
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
ImmunoGen, Inc. (IMGN) $10.86 - - 1.46B Strong Buy
Envision Healthcare Corp (EVHC) $37.66 - - 4.32B Strong Buy
DURECT Corporation (DRRX) $1.12 - - 176.8M Strong Buy
Endo International PLC (ENDP) $6.56 - - 1.52B Strong Buy
STRATA Skin Sciences Inc (SSKN) $1.33 - - 5.7M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More